Brain Circulation (Jan 2021)

Exception from informed consent in the era of social media: The SEGA stroke trial experience

  • Mehmet Enes Inam,
  • Aditya Sanzgiri,
  • Elvira Lekka,
  • Sunil A Sheth,
  • Andrew D Barreto,
  • Sean I Savitz,
  • Carlos Artime,
  • Claudia Pedroza,
  • Allison Engstrom,
  • Faheem G Sheriff,
  • Alexander Ambrocik,
  • Peng Roc Chen

DOI
https://doi.org/10.4103/bc.bc_44_21
Journal volume & issue
Vol. 7, no. 4
pp. 253 – 258

Abstract

Read online

INTRODUCTION: Patients with acute ischemic stroke (AIS) and neurologic deficits are often unable to provide consent and excluded from emergency research participation. Experiences with exception from informed consent (EFIC) to facilitate research on potentially life-saving emergency interventions are limited. Here, we describe our multifaceted approach to EFIC approval for an ongoing randomized clinical trial that compares sedation versus general anesthesia (SEGA) approaches for endovascular thrombectomy during AIS. METHODS: We published a university clinical trial website with EFIC information. We initiated a social media campaign on Facebook within a 50 mile radius of Texas Medical Center. Advertisements were linked to our website, and a press release was issued with information about the trial. In-person community consultations were performed, and voluntary survey information was collected. RESULTS: A total of 193 individuals (65% female, age 46.7 ± 16.6 years) participated in seven focus group community consultations. Of the 144 (75%) that completed surveys, 88.7% agreed that they would be willing to have themselves or family enrolled in this trial under EFIC. Facebook advertisements had 134,481 (52% females; 60% ≥45 years old) views followed by 1,630 clicks to learn more. The website had 1130 views (56% regional and 44% national) with an average of 3.85 min spent. Our Institutional Review Board received zero e-mails requesting additional information or to optout. CONCLUSION: Our social media campaign and community consultation methods provide a significant outreach to potential stroke patients. We hope that our experience will inform and help future efforts for trials seeking EFIC.

Keywords